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Introduction 
Osteoarthritis (OA) is the most common joint disease 
worldwide with only limited treatment options
1
. It is 
believed that the thorough analyses of the disease on 
cellular and molecular base can lead us to the discovery of 
new targets, and to the development of new therapies. 
Thus, we have been working on the development of a 3D 
model of human OA knee cartilage. By this in vitro model, 
it is expected to gain a better understanding on the disease 
process. The two main aspects of our research are: (1) how 
the mechanical loading and (2) how the presence of pro-
inflammatory cytokines, e.g. TNF-α and IL1-β affects the 
degenerative processes
2,3
. In the present study, we 
demonstrated the effect of the different cytokines on 
monolayer and tissue culture.  
Materials and Methods 
All human cartilage samples were obtained from the local 
hospital. The cartilage pieces were harvested from the 
lateral-central regions of both the femurs. The biopsy 
specimens as well as the cell monolayers were cultured in 
tissue culture polystyrene (TCPS) multi-well plates, 
immersed in Dulbecco’s modified Eagle’s medium 
(DMEM) (Sigma – Aldrich, USA) with phenol red, 
supplemented with 10% foetal bovine serum (FBS) 
(Biochrone, Berlin, Germany) 1% antibiotic-antimycotic 
solution (Invitrogen, USA) and cytokines TNF-α, and IL1-
β (R&D systems – Minneapolis, USA) and incubated for 6 
days at 37C, 5% CO2, within static conditions (ATM  
0.1MPA). The cellular viability was assessed by 
Live/Dead® Viability Assay (C3099, P1304MP, 
Invitrogen). Cell metabolic activity was evaluated by MTS 
(3-(4,5-dimethylthiazol-2-yl)-5(3-rboxymethoxyphenyl)-
2(4-sulfofenyl)-2H-tetrazolium) assay (G3581, CellTiter 
96® AQueous Assay, Madison, WI, USA). GAG content 
of the cartilage biopsy specimens was assessed by Safranin 
O staining. 
Results 
The cell morphology of the chondrocytes was altered as a 
consequence of cytokine treatment. Instead of the roundish 
phenotype elongated fibroblastic cells were observed after 
6 days of incubation with cytokines (Fig.1). Cell viability 
showed lower rates when cytokine was added in the culture 
media as it is shown by the Live/Dead assays, however the 
MTS assay indicated an increasing cell metabolic activity 
in the presence of cytokines. The tissue culture showed 
accelerated degradation processes and increased GAG 
loss when the media was supplemented with cytokines as 
it was shown by Safranin O and Fast green staining on 
the histological images.  
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
The performed studies showed that the cytokines lead the 
chondrocytes towards the osteoarthritic phenotype and 
accelerate the degradation processes in the cartilage 
tissue as it was expected, therefore ideal agents for the 
development of the envisioned 3D OA cartilage model. 
However, further studies are needed to evaluate the 
effects of cytokines on molecular and gene level.  
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Figure 1. Cell viability - Live/Dead assay.  A – B, healthy 
chondrocytes, 25ng/ml IL-1ß, 100 ng/ml TNF-α; E – F:  OA 
chondrocytes 25ng/ml IL-1ß, 100 ng/ml TNF-α; C – D: control, 
healthy chondrocytes, G – F: control, OA chondrocytes. 
